Comments
Commented by Stefan Feulner on January 20th, 2022 | 11:01 CET
BrainChip, Prospect Ridge Resources, ASML - Ready for the mass market
Sentiment on the stock market continues to cloud over. Investors worry that the US Federal Reserve will fight the sharp rise in inflation by intervening more quickly with several interest rate hikes, causing prices worldwide to plummet. There is hardly any movement on the precious metals market, with gold remaining in the USD 1,800 range. On the other hand, the stock of a next-generation chip producer, which seems ready for the mass market, has moved.
Read
Commented by Stefan Feulner on January 20th, 2022 | 10:36 CET
Nel ASA, Alerio Gold, Siemens - Difficult times
Following the outbreak of the Corona pandemic, with its lockdowns and restrictions, the DAX has been going nowhere but up since its low of 7968.50 points on March 16, 2020. The world's leading indices also posted one high after another. Now the mood is changing due to fears of a tighter monetary policy by central banks. The question will be whether financial guardians can contain skyrocketing inflation rates without choking off growth. Along the way, the focus is likely to be on the sovereign debt ratios, which are rising sharply. It is unlikely to be possible to raise key interest rates too much. Therefore, even if the precious metals remain in a short-term correction, gold is likely to be one of the winners of the current process.
Read
Commented by Stefan Feulner on January 20th, 2022 | 09:15 CET
Valneva, XPhyto, BioNTech - This is the breakthrough
The shares of vaccine manufacturers are currently experiencing a rollercoaster ride. While BioNTech, Pfizer and Moderna vaccines, based on mRNA technology, continue to reduce their incredible stock market valuation, Valneva, the manufacturer of an inactivated vaccine, has made a brilliant comeback on the stock market floor. The reasons for the good mood were positive data regarding the neutralization of the Omicron variant, which pushed the share up by more than 30% after trading hours.
Read
Commented by Mario Hose on January 19th, 2022 | 14:51 CET
Trading shares in focus: BrainChip, Gazprom, Saturn Oil + Gas
The German indices have reached on the second day of the week after a bumpy start to trading now again positive signs. The German benchmark index DAX traded at a level of 15,824 points and thus around 0.28% in the plus, in the daily low has held the mark of 15,600 points and since then goes upwards. The MDAX last traded at 34,172 points (+0.05%), TexDAX at 3,532 points (+1.28%) and SDAX at 15,613 points with 0.03% up. Exciting individual stocks offer interesting investment opportunities.
Read
Commented by Nico Popp on January 19th, 2022 | 14:13 CET
Gold rush in the lithium market: BMW, Yorkton Ventures, Rock Tech Lithium
An entire industry is turning itself inside out. The revolution in the car market will pick up speed in the coming years. As a study by Deloitte shows, sales of battery-powered vehicles could rise from 210,000 in 2022 to 960,000 in 2030. Between 2022 and 2026 alone, market experts expect sales of electric cars in Germany to double. So it is no wonder that a gold-rush mood is already spreading around some companies. We take a closer look at three shares.
Read
Commented by André Will-Laudien on January 19th, 2022 | 13:45 CET
BYD, Almonty Industries, Varta - E-mobility needs critical metals!
The pandemic has disrupted supply chains in the raw materials sector. In Brandenburg, a new Tesla electric car is expected to roll off the assembly line every 45 seconds in the future. But the permits for the water supply are dragging on. The new plant was supposed to go "online" in 2021. In addition to the regulatory requirements, however, it is primarily the availability of scarce raw materials that hamper the innovative spirit of the high-tech industry today. In particular, metals and battery raw materials are in high demand and have become a bone of contention in globalization. We look at both sides of the increasingly complex supply relationship.
Read
Commented by Armin Schulz on January 19th, 2022 | 13:14 CET
Novavax, Meta Materials, BASF - Innovations offer great return opportunities
Companies that provide innovations to solve existing problems are ideal investment targets. Filtering out suitable candidates is the most critical task for an investor. Some products require little explanation. For companies developing advanced technologies, patents can give an indication of the Company's future prospects. In any case, the market that the products can serve should be analyzed. Today, we look at three innovative companies.
Read
Commented by Nico Popp on January 19th, 2022 | 10:59 CET
NEL, dynaCERT, Volkswagen: Will the last be first?
Energy prices are going through the roof. Anyone who has to change their energy supplier these days is in for a surprise. Surcharges of 50% and more for electricity and gas are not uncommon. In this context, questions about the drives of the future are becoming louder again. Although hydrogen also has a high energy requirement, the German Federal Ministry of Economics and Technology promotes green hydrogen as a lower levy under the Renewable Energy Sources Act. Reason enough to take a closer look at some stocks related to hydrogen and mobility.
Read
Commented by Mario Hose on January 18th, 2022 | 16:37 CET
Buy Long-Covid Stock Now? BioNTech, Cardiol, Mainz Biomed
The second trading day this week is characterized by a weak start to trading. In the first two hours, the German indices have clearly lost ground. The leading index DAX is currently trading at 15,776 points, down around 1.05% on the previous day. The MDAX last traded at 34,156 points (-1.38%), TecDAX at 3,498 points (-1.77%) and SDAX at 15,658 points with 1.65% in the red. In the focus of market participants today are repeatedly the shares of vaccine manufacturers, but the trend is now also to the next phase of the Corona situation, the treatment of Long-Covid.
Read
Commented by Carsten Mainitz on January 18th, 2022 | 13:07 CET
Ayurcann, Novavax, Covestro - The stragglers are coming!
Humanity continues to find itself in the clutches of the Corona pandemic, the infection figures are rising, and the demand from politicians for mandatory vaccination is becoming louder and louder. While BioNTech and Pfizer vaccines and Moderna have dominated to date, new vaccine manufacturers are entering the market in the next wave. The situation is similar in the cannabis industry. After a boom about 3 years ago, the market leaders have since lost up to 80% of their value. Legalization and the rise of Cannabis 3.0. will pave the way for new companies.
Read